nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A1—hematologic cancer	0.29	1	CbGaD
Phenoxybenzamine—SLC22A3—Melphalan—hematologic cancer	0.0851	0.175	CbGbCtD
Phenoxybenzamine—SLC22A2—Daunorubicin—hematologic cancer	0.0357	0.0733	CbGbCtD
Phenoxybenzamine—SLC22A2—Cytarabine—hematologic cancer	0.0315	0.0647	CbGbCtD
Phenoxybenzamine—SLC22A2—Cladribine—hematologic cancer	0.0297	0.0611	CbGbCtD
Phenoxybenzamine—SLC22A3—Irinotecan—hematologic cancer	0.0288	0.0593	CbGbCtD
Phenoxybenzamine—SLC22A1—Cytarabine—hematologic cancer	0.0273	0.0562	CbGbCtD
Phenoxybenzamine—SLC22A2—Imatinib—hematologic cancer	0.0273	0.0562	CbGbCtD
Phenoxybenzamine—SLC22A1—Cladribine—hematologic cancer	0.0258	0.0531	CbGbCtD
Phenoxybenzamine—SLC22A3—Vincristine—hematologic cancer	0.0252	0.0518	CbGbCtD
Phenoxybenzamine—SLC22A1—Imatinib—hematologic cancer	0.0237	0.0488	CbGbCtD
Phenoxybenzamine—SLC22A2—Vinblastine—hematologic cancer	0.0152	0.0312	CbGbCtD
Phenoxybenzamine—SLC22A2—Cisplatin—hematologic cancer	0.0139	0.0286	CbGbCtD
Phenoxybenzamine—CYP3A4—Bexarotene—hematologic cancer	0.0097	0.0199	CbGbCtD
Phenoxybenzamine—CYP3A4—Lomustine—hematologic cancer	0.00902	0.0185	CbGbCtD
Phenoxybenzamine—CYP3A4—Busulfan—hematologic cancer	0.00902	0.0185	CbGbCtD
Phenoxybenzamine—CYP3A4—Thiotepa—hematologic cancer	0.00804	0.0165	CbGbCtD
Phenoxybenzamine—CYP3A4—Methoxsalen—hematologic cancer	0.00625	0.0129	CbGbCtD
Phenoxybenzamine—CYP3A4—Bortezomib—hematologic cancer	0.00595	0.0122	CbGbCtD
Phenoxybenzamine—CYP3A4—Daunorubicin—hematologic cancer	0.00569	0.0117	CbGbCtD
Phenoxybenzamine—CYP3A4—Cytarabine—hematologic cancer	0.00502	0.0103	CbGbCtD
Phenoxybenzamine—CYP3A4—Teniposide—hematologic cancer	0.00494	0.0102	CbGbCtD
Phenoxybenzamine—CYP3A4—Ifosfamide—hematologic cancer	0.00456	0.00938	CbGbCtD
Phenoxybenzamine—CYP3A4—Imatinib—hematologic cancer	0.00436	0.00896	CbGbCtD
Phenoxybenzamine—CYP3A4—Ruxolitinib—hematologic cancer	0.0041	0.00844	CbGbCtD
Phenoxybenzamine—CYP3A4—Nilotinib—hematologic cancer	0.00396	0.00814	CbGbCtD
Phenoxybenzamine—CYP3A4—Vinorelbine—hematologic cancer	0.00393	0.00807	CbGbCtD
Phenoxybenzamine—CYP3A4—Triamcinolone—hematologic cancer	0.00359	0.00738	CbGbCtD
Phenoxybenzamine—CYP3A4—Dasatinib—hematologic cancer	0.0035	0.00719	CbGbCtD
Phenoxybenzamine—CYP3A4—Mitoxantrone—hematologic cancer	0.00346	0.00711	CbGbCtD
Phenoxybenzamine—CYP3A4—Betamethasone—hematologic cancer	0.00308	0.00633	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisolone—hematologic cancer	0.00304	0.00625	CbGbCtD
Phenoxybenzamine—CYP3A4—Prednisone—hematologic cancer	0.00287	0.0059	CbGbCtD
Phenoxybenzamine—CYP3A4—Irinotecan—hematologic cancer	0.00272	0.0056	CbGbCtD
Phenoxybenzamine—CYP3A4—Vinblastine—hematologic cancer	0.00242	0.00497	CbGbCtD
Phenoxybenzamine—Gastrointestinal tract irritation—Lenalidomide—hematologic cancer	0.00241	0.048	CcSEcCtD
Phenoxybenzamine—CYP3A4—Vincristine—hematologic cancer	0.00238	0.00489	CbGbCtD
Phenoxybenzamine—CYP3A4—Etoposide—hematologic cancer	0.00218	0.00448	CbGbCtD
Phenoxybenzamine—CYP3A4—Dexamethasone—hematologic cancer	0.00179	0.00368	CbGbCtD
Phenoxybenzamine—Miosis—Irinotecan—hematologic cancer	0.00152	0.0304	CcSEcCtD
Phenoxybenzamine—CYP3A4—Doxorubicin—hematologic cancer	0.00149	0.00306	CbGbCtD
Phenoxybenzamine—Orthostatic hypotension—Anagrelide—hematologic cancer	0.000861	0.0172	CcSEcCtD
Phenoxybenzamine—SLC22A3—hematopoietic system—hematologic cancer	0.000786	0.0476	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Anagrelide—hematologic cancer	0.000781	0.0156	CcSEcCtD
Phenoxybenzamine—Fatigue—Ruxolitinib—hematologic cancer	0.0007	0.014	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Lenalidomide—hematologic cancer	0.000685	0.0136	CcSEcCtD
Phenoxybenzamine—CALM2—hematopoietic system—hematologic cancer	0.000668	0.0405	CbGeAlD
Phenoxybenzamine—CALM1—hematopoietic system—hematologic cancer	0.000665	0.0403	CbGeAlD
Phenoxybenzamine—ADRA1A—hematopoietic system—hematologic cancer	0.000626	0.0379	CbGeAlD
Phenoxybenzamine—Drowsiness—Procarbazine—hematologic cancer	0.000612	0.0122	CcSEcCtD
Phenoxybenzamine—SLC22A3—gonad—hematologic cancer	0.000598	0.0362	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Nilotinib—hematologic cancer	0.000596	0.0119	CcSEcCtD
Phenoxybenzamine—Fatigue—Vorinostat—hematologic cancer	0.000592	0.0118	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Cladribine—hematologic cancer	0.000583	0.0116	CcSEcCtD
Phenoxybenzamine—Asthenia—Ruxolitinib—hematologic cancer	0.000582	0.0116	CcSEcCtD
Phenoxybenzamine—CALM3—blood—hematologic cancer	0.000563	0.0341	CbGeAlD
Phenoxybenzamine—CALM3—bone marrow—hematologic cancer	0.000545	0.033	CbGeAlD
Phenoxybenzamine—SLC22A1—blood—hematologic cancer	0.000545	0.033	CbGeAlD
Phenoxybenzamine—Nasal congestion—Alitretinoin—hematologic cancer	0.000541	0.0108	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Bortezomib—hematologic cancer	0.000524	0.0105	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Lenalidomide—hematologic cancer	0.000517	0.0103	CcSEcCtD
Phenoxybenzamine—CALM2—gonad—hematologic cancer	0.000508	0.0308	CbGeAlD
Phenoxybenzamine—CALM1—gonad—hematologic cancer	0.000505	0.0306	CbGeAlD
Phenoxybenzamine—CALM3—lung—hematologic cancer	0.000494	0.0299	CbGeAlD
Phenoxybenzamine—Asthenia—Vorinostat—hematologic cancer	0.000492	0.00981	CcSEcCtD
Phenoxybenzamine—ADRA2A—hematopoietic system—hematologic cancer	0.000476	0.0289	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Bortezomib—hematologic cancer	0.000476	0.00948	CcSEcCtD
Phenoxybenzamine—Drowsiness—Hydroxyurea—hematologic cancer	0.000474	0.00945	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Thalidomide—hematologic cancer	0.000473	0.00943	CcSEcCtD
Phenoxybenzamine—CALM3—testis—hematologic cancer	0.000466	0.0282	CbGeAlD
Phenoxybenzamine—Nasal congestion—Cisplatin—hematologic cancer	0.000461	0.00918	CcSEcCtD
Phenoxybenzamine—SLC22A3—lung—hematologic cancer	0.000457	0.0277	CbGeAlD
Phenoxybenzamine—Tachycardia—Daunorubicin—hematologic cancer	0.000454	0.00905	CcSEcCtD
Phenoxybenzamine—Tachycardia—Clofarabine—hematologic cancer	0.000454	0.00905	CcSEcCtD
Phenoxybenzamine—Tachycardia—Pentostatin—hematologic cancer	0.000452	0.00901	CcSEcCtD
Phenoxybenzamine—Tachycardia—Anagrelide—hematologic cancer	0.000452	0.00901	CcSEcCtD
Phenoxybenzamine—CALM2—blood—hematologic cancer	0.000442	0.0268	CbGeAlD
Phenoxybenzamine—Somnolence—Nelarabine—hematologic cancer	0.000442	0.00881	CcSEcCtD
Phenoxybenzamine—CALM1—blood—hematologic cancer	0.00044	0.0267	CbGeAlD
Phenoxybenzamine—SLC22A3—testis—hematologic cancer	0.000431	0.0261	CbGeAlD
Phenoxybenzamine—Fatigue—Nelarabine—hematologic cancer	0.000429	0.00854	CcSEcCtD
Phenoxybenzamine—CALM2—bone marrow—hematologic cancer	0.000428	0.0259	CbGeAlD
Phenoxybenzamine—CALM1—bone marrow—hematologic cancer	0.000426	0.0258	CbGeAlD
Phenoxybenzamine—Tachycardia—Teniposide—hematologic cancer	0.000424	0.00845	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Irinotecan—hematologic cancer	0.000422	0.00842	CcSEcCtD
Phenoxybenzamine—ADRA1A—blood—hematologic cancer	0.000415	0.0251	CbGeAlD
Phenoxybenzamine—Somnolence—Daunorubicin—hematologic cancer	0.000414	0.00824	CcSEcCtD
Phenoxybenzamine—Somnolence—Clofarabine—hematologic cancer	0.000414	0.00824	CcSEcCtD
Phenoxybenzamine—Somnolence—Pentostatin—hematologic cancer	0.000412	0.00821	CcSEcCtD
Phenoxybenzamine—Somnolence—Anagrelide—hematologic cancer	0.000412	0.00821	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Alitretinoin—hematologic cancer	0.000408	0.00814	CcSEcCtD
Phenoxybenzamine—Fatigue—Clofarabine—hematologic cancer	0.000401	0.00799	CcSEcCtD
Phenoxybenzamine—Fatigue—Daunorubicin—hematologic cancer	0.000401	0.00799	CcSEcCtD
Phenoxybenzamine—Fatigue—Pentostatin—hematologic cancer	0.000399	0.00796	CcSEcCtD
Phenoxybenzamine—Fatigue—Anagrelide—hematologic cancer	0.000399	0.00796	CcSEcCtD
Phenoxybenzamine—Drowsiness—Thalidomide—hematologic cancer	0.000399	0.00795	CcSEcCtD
Phenoxybenzamine—ADRA2C—blood—hematologic cancer	0.000395	0.024	CbGeAlD
Phenoxybenzamine—Tachycardia—Busulfan—hematologic cancer	0.000393	0.00783	CcSEcCtD
Phenoxybenzamine—CALM2—lung—hematologic cancer	0.000388	0.0235	CbGeAlD
Phenoxybenzamine—CALM1—lung—hematologic cancer	0.000386	0.0234	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Cisplatin—hematologic cancer	0.000383	0.00764	CcSEcCtD
Phenoxybenzamine—Tachycardia—Procarbazine—hematologic cancer	0.000381	0.0076	CcSEcCtD
Phenoxybenzamine—Drowsiness—Alitretinoin—hematologic cancer	0.00038	0.00757	CcSEcCtD
Phenoxybenzamine—CYP3A4—hematopoietic system—hematologic cancer	0.000375	0.0227	CbGeAlD
Phenoxybenzamine—Tachycardia—Dasatinib—hematologic cancer	0.000374	0.00745	CcSEcCtD
Phenoxybenzamine—Tachycardia—Bexarotene—hematologic cancer	0.000374	0.00745	CcSEcCtD
Phenoxybenzamine—CALM2—testis—hematologic cancer	0.000366	0.0222	CbGeAlD
Phenoxybenzamine—CALM1—testis—hematologic cancer	0.000364	0.0221	CbGeAlD
Phenoxybenzamine—ADRA2A—gonad—hematologic cancer	0.000362	0.0219	CbGeAlD
Phenoxybenzamine—Somnolence—Busulfan—hematologic cancer	0.000358	0.00713	CcSEcCtD
Phenoxybenzamine—Asthenia—Nelarabine—hematologic cancer	0.000357	0.00711	CcSEcCtD
Phenoxybenzamine—Drowsiness—Mitoxantrone—hematologic cancer	0.000356	0.0071	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Cisplatin—hematologic cancer	0.000348	0.00693	CcSEcCtD
Phenoxybenzamine—Somnolence—Procarbazine—hematologic cancer	0.000347	0.00692	CcSEcCtD
Phenoxybenzamine—Fatigue—Busulfan—hematologic cancer	0.000347	0.00692	CcSEcCtD
Phenoxybenzamine—ADRA2C—lung—hematologic cancer	0.000347	0.021	CbGeAlD
Phenoxybenzamine—Tachycardia—Nilotinib—hematologic cancer	0.000345	0.00688	CcSEcCtD
Phenoxybenzamine—Tachycardia—Imatinib—hematologic cancer	0.000343	0.00684	CcSEcCtD
Phenoxybenzamine—Somnolence—Dasatinib—hematologic cancer	0.00034	0.00679	CcSEcCtD
Phenoxybenzamine—Somnolence—Bexarotene—hematologic cancer	0.00034	0.00679	CcSEcCtD
Phenoxybenzamine—CALM3—lymph node—hematologic cancer	0.000338	0.0205	CbGeAlD
Phenoxybenzamine—Tachycardia—Cladribine—hematologic cancer	0.000337	0.00672	CcSEcCtD
Phenoxybenzamine—Fatigue—Procarbazine—hematologic cancer	0.000337	0.00671	CcSEcCtD
Phenoxybenzamine—Asthenia—Daunorubicin—hematologic cancer	0.000334	0.00665	CcSEcCtD
Phenoxybenzamine—Asthenia—Clofarabine—hematologic cancer	0.000334	0.00665	CcSEcCtD
Phenoxybenzamine—Asthenia—Pentostatin—hematologic cancer	0.000332	0.00662	CcSEcCtD
Phenoxybenzamine—Asthenia—Anagrelide—hematologic cancer	0.000332	0.00662	CcSEcCtD
Phenoxybenzamine—Fatigue—Dasatinib—hematologic cancer	0.00033	0.00658	CcSEcCtD
Phenoxybenzamine—Fatigue—Bexarotene—hematologic cancer	0.00033	0.00658	CcSEcCtD
Phenoxybenzamine—Fatigue—Fludarabine—hematologic cancer	0.000329	0.00656	CcSEcCtD
Phenoxybenzamine—ADRA2C—testis—hematologic cancer	0.000327	0.0198	CbGeAlD
Phenoxybenzamine—ADRA2A—blood—hematologic cancer	0.000316	0.0191	CbGeAlD
Phenoxybenzamine—Somnolence—Imatinib—hematologic cancer	0.000313	0.00623	CcSEcCtD
Phenoxybenzamine—SLC22A3—lymph node—hematologic cancer	0.000312	0.0189	CbGeAlD
Phenoxybenzamine—Fatigue—Chlorambucil—hematologic cancer	0.000312	0.00622	CcSEcCtD
Phenoxybenzamine—Asthenia—Teniposide—hematologic cancer	0.000312	0.00621	CcSEcCtD
Phenoxybenzamine—Tachycardia—Melphalan—hematologic cancer	0.000308	0.00613	CcSEcCtD
Phenoxybenzamine—Somnolence—Cladribine—hematologic cancer	0.000307	0.00613	CcSEcCtD
Phenoxybenzamine—Fatigue—Nilotinib—hematologic cancer	0.000305	0.00608	CcSEcCtD
Phenoxybenzamine—Fatigue—Imatinib—hematologic cancer	0.000303	0.00605	CcSEcCtD
Phenoxybenzamine—Tachycardia—Lenalidomide—hematologic cancer	0.000299	0.00596	CcSEcCtD
Phenoxybenzamine—Fatigue—Cladribine—hematologic cancer	0.000298	0.00594	CcSEcCtD
Phenoxybenzamine—Asthenia—Busulfan—hematologic cancer	0.000289	0.00576	CcSEcCtD
Phenoxybenzamine—Asthenia—Procarbazine—hematologic cancer	0.00028	0.00559	CcSEcCtD
Phenoxybenzamine—ADRA2A—lung—hematologic cancer	0.000277	0.0168	CbGeAlD
Phenoxybenzamine—Tachycardia—Bortezomib—hematologic cancer	0.000275	0.00549	CcSEcCtD
Phenoxybenzamine—Asthenia—Bexarotene—hematologic cancer	0.000275	0.00548	CcSEcCtD
Phenoxybenzamine—Asthenia—Dasatinib—hematologic cancer	0.000275	0.00548	CcSEcCtD
Phenoxybenzamine—Asthenia—Fludarabine—hematologic cancer	0.000274	0.00546	CcSEcCtD
Phenoxybenzamine—Somnolence—Lenalidomide—hematologic cancer	0.000273	0.00543	CcSEcCtD
Phenoxybenzamine—Fatigue—Melphalan—hematologic cancer	0.000272	0.00542	CcSEcCtD
Phenoxybenzamine—Tachycardia—Vinorelbine—hematologic cancer	0.000269	0.00536	CcSEcCtD
Phenoxybenzamine—Somnolence—Hydroxyurea—hematologic cancer	0.000269	0.00536	CcSEcCtD
Phenoxybenzamine—CALM2—lymph node—hematologic cancer	0.000265	0.0161	CbGeAlD
Phenoxybenzamine—Fatigue—Lenalidomide—hematologic cancer	0.000264	0.00527	CcSEcCtD
Phenoxybenzamine—CALM1—lymph node—hematologic cancer	0.000264	0.016	CbGeAlD
Phenoxybenzamine—ADRA2A—testis—hematologic cancer	0.000261	0.0158	CbGeAlD
Phenoxybenzamine—Fatigue—Hydroxyurea—hematologic cancer	0.000261	0.0052	CcSEcCtD
Phenoxybenzamine—Asthenia—Chlorambucil—hematologic cancer	0.00026	0.00517	CcSEcCtD
Phenoxybenzamine—Tachycardia—Thiotepa—hematologic cancer	0.000257	0.00512	CcSEcCtD
Phenoxybenzamine—Asthenia—Nilotinib—hematologic cancer	0.000254	0.00506	CcSEcCtD
Phenoxybenzamine—Asthenia—Imatinib—hematologic cancer	0.000252	0.00503	CcSEcCtD
Phenoxybenzamine—CYP3A4—blood—hematologic cancer	0.000248	0.015	CbGeAlD
Phenoxybenzamine—Tachycardia—Thalidomide—hematologic cancer	0.000248	0.00495	CcSEcCtD
Phenoxybenzamine—Asthenia—Cladribine—hematologic cancer	0.000248	0.00494	CcSEcCtD
Phenoxybenzamine—Fatigue—Bortezomib—hematologic cancer	0.000243	0.00485	CcSEcCtD
Phenoxybenzamine—Tachycardia—Carmustine—hematologic cancer	0.000239	0.00475	CcSEcCtD
Phenoxybenzamine—Asthenia—Vinblastine—hematologic cancer	0.000238	0.00474	CcSEcCtD
Phenoxybenzamine—Fatigue—Vinorelbine—hematologic cancer	0.000237	0.00473	CcSEcCtD
Phenoxybenzamine—ADRA2C—lymph node—hematologic cancer	0.000237	0.0144	CbGeAlD
Phenoxybenzamine—Ospemifene—ESR1—hematologic cancer	0.000237	0.179	CrCbGaD
Phenoxybenzamine—Tachycardia—Alitretinoin—hematologic cancer	0.000236	0.00471	CcSEcCtD
Phenoxybenzamine—Somnolence—Thiotepa—hematologic cancer	0.000234	0.00466	CcSEcCtD
Phenoxybenzamine—Fatigue—Thiotepa—hematologic cancer	0.000227	0.00452	CcSEcCtD
Phenoxybenzamine—Asthenia—Melphalan—hematologic cancer	0.000226	0.00451	CcSEcCtD
Phenoxybenzamine—Somnolence—Thalidomide—hematologic cancer	0.000226	0.00451	CcSEcCtD
Phenoxybenzamine—Tachycardia—Mitoxantrone—hematologic cancer	0.000222	0.00442	CcSEcCtD
Phenoxybenzamine—Asthenia—Lenalidomide—hematologic cancer	0.00022	0.00438	CcSEcCtD
Phenoxybenzamine—Fatigue—Thalidomide—hematologic cancer	0.000219	0.00437	CcSEcCtD
Phenoxybenzamine—Somnolence—Carmustine—hematologic cancer	0.000217	0.00433	CcSEcCtD
Phenoxybenzamine—Asthenia—Hydroxyurea—hematologic cancer	0.000217	0.00432	CcSEcCtD
Phenoxybenzamine—Somnolence—Alitretinoin—hematologic cancer	0.000215	0.00429	CcSEcCtD
Phenoxybenzamine—Somnolence—Ifosfamide—hematologic cancer	0.000213	0.00424	CcSEcCtD
Phenoxybenzamine—Fatigue—Alitretinoin—hematologic cancer	0.000209	0.00416	CcSEcCtD
Phenoxybenzamine—Fatigue—Ifosfamide—hematologic cancer	0.000206	0.00411	CcSEcCtD
Phenoxybenzamine—Asthenia—Bortezomib—hematologic cancer	0.000202	0.00403	CcSEcCtD
Phenoxybenzamine—Somnolence—Mitoxantrone—hematologic cancer	0.000202	0.00403	CcSEcCtD
Phenoxybenzamine—Somnolence—Irinotecan—hematologic cancer	0.000202	0.00403	CcSEcCtD
Phenoxybenzamine—Tachycardia—Cisplatin—hematologic cancer	0.000201	0.00401	CcSEcCtD
Phenoxybenzamine—Fatigue—Vincristine—hematologic cancer	0.000201	0.00401	CcSEcCtD
Phenoxybenzamine—Asthenia—Bleomycin—hematologic cancer	0.000201	0.004	CcSEcCtD
Phenoxybenzamine—Asthenia—Vinorelbine—hematologic cancer	0.000198	0.00394	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Epirubicin—hematologic cancer	0.000197	0.00392	CcSEcCtD
Phenoxybenzamine—Somnolence—Gemcitabine—hematologic cancer	0.000197	0.00392	CcSEcCtD
Phenoxybenzamine—Fatigue—Irinotecan—hematologic cancer	0.000196	0.0039	CcSEcCtD
Phenoxybenzamine—Fatigue—Mitoxantrone—hematologic cancer	0.000196	0.0039	CcSEcCtD
Phenoxybenzamine—Toremifene—ESR1—hematologic cancer	0.000193	0.146	CrCbGaD
Phenoxybenzamine—Abdominal discomfort—Methotrexate—hematologic cancer	0.000191	0.0038	CcSEcCtD
Phenoxybenzamine—Fatigue—Gemcitabine—hematologic cancer	0.000191	0.0038	CcSEcCtD
Phenoxybenzamine—ADRA2A—lymph node—hematologic cancer	0.000189	0.0115	CbGeAlD
Phenoxybenzamine—Asthenia—Thiotepa—hematologic cancer	0.000189	0.00376	CcSEcCtD
Phenoxybenzamine—Tachycardia—Etoposide—hematologic cancer	0.000184	0.00368	CcSEcCtD
Phenoxybenzamine—Asthenia—Thalidomide—hematologic cancer	0.000183	0.00364	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000182	0.00363	CcSEcCtD
Phenoxybenzamine—Tachycardia—Prednisolone—hematologic cancer	0.000182	0.00363	CcSEcCtD
Phenoxybenzamine—Drowsiness—Methotrexate—hematologic cancer	0.000177	0.00354	CcSEcCtD
Phenoxybenzamine—Asthenia—Carmustine—hematologic cancer	0.000175	0.0035	CcSEcCtD
Phenoxybenzamine—Asthenia—Alitretinoin—hematologic cancer	0.000174	0.00346	CcSEcCtD
Phenoxybenzamine—Asthenia—Ifosfamide—hematologic cancer	0.000172	0.00342	CcSEcCtD
Phenoxybenzamine—Somnolence—Etoposide—hematologic cancer	0.000168	0.00335	CcSEcCtD
Phenoxybenzamine—Asthenia—Vincristine—hematologic cancer	0.000167	0.00334	CcSEcCtD
Phenoxybenzamine—Tachycardia—Triamcinolone—hematologic cancer	0.000167	0.00333	CcSEcCtD
Phenoxybenzamine—Clomifene—ESR1—hematologic cancer	0.000167	0.126	CrCbGaD
Phenoxybenzamine—Drowsiness—Epirubicin—hematologic cancer	0.000166	0.00331	CcSEcCtD
Phenoxybenzamine—Asthenia—Mitoxantrone—hematologic cancer	0.000163	0.00325	CcSEcCtD
Phenoxybenzamine—Asthenia—Irinotecan—hematologic cancer	0.000163	0.00325	CcSEcCtD
Phenoxybenzamine—Fatigue—Etoposide—hematologic cancer	0.000163	0.00325	CcSEcCtD
Phenoxybenzamine—Asthenia—Gemcitabine—hematologic cancer	0.000159	0.00317	CcSEcCtD
Phenoxybenzamine—Drowsiness—Doxorubicin—hematologic cancer	0.000154	0.00306	CcSEcCtD
Phenoxybenzamine—Tachycardia—Betamethasone—hematologic cancer	0.000152	0.00303	CcSEcCtD
Phenoxybenzamine—Tachycardia—Dexamethasone—hematologic cancer	0.000152	0.00303	CcSEcCtD
Phenoxybenzamine—Asthenia—Cisplatin—hematologic cancer	0.000148	0.00295	CcSEcCtD
Phenoxybenzamine—Fatigue—Triamcinolone—hematologic cancer	0.000148	0.00295	CcSEcCtD
Phenoxybenzamine—Asthenia—Etoposide—hematologic cancer	0.000136	0.0027	CcSEcCtD
Phenoxybenzamine—Fatigue—Betamethasone—hematologic cancer	0.000134	0.00267	CcSEcCtD
Phenoxybenzamine—Fatigue—Dexamethasone—hematologic cancer	0.000134	0.00267	CcSEcCtD
Phenoxybenzamine—Tachycardia—Prednisone—hematologic cancer	0.000132	0.00263	CcSEcCtD
Phenoxybenzamine—Asthenia—Triamcinolone—hematologic cancer	0.000123	0.00245	CcSEcCtD
Phenoxybenzamine—Fatigue—Prednisone—hematologic cancer	0.000117	0.00233	CcSEcCtD
Phenoxybenzamine—Diphenhydramine—SLC22A1—hematologic cancer	0.000116	0.0874	CrCbGaD
Phenoxybenzamine—Asthenia—Dexamethasone—hematologic cancer	0.000112	0.00222	CcSEcCtD
Phenoxybenzamine—Asthenia—Betamethasone—hematologic cancer	0.000112	0.00222	CcSEcCtD
Phenoxybenzamine—Tachycardia—Epirubicin—hematologic cancer	0.000103	0.00206	CcSEcCtD
Phenoxybenzamine—Somnolence—Methotrexate—hematologic cancer	0.000101	0.00201	CcSEcCtD
Phenoxybenzamine—Fatigue—Methotrexate—hematologic cancer	9.76e-05	0.00195	CcSEcCtD
Phenoxybenzamine—Asthenia—Prednisone—hematologic cancer	9.72e-05	0.00194	CcSEcCtD
Phenoxybenzamine—Tachycardia—Doxorubicin—hematologic cancer	9.57e-05	0.00191	CcSEcCtD
Phenoxybenzamine—Somnolence—Epirubicin—hematologic cancer	9.42e-05	0.00188	CcSEcCtD
Phenoxybenzamine—Fatigue—Epirubicin—hematologic cancer	9.13e-05	0.00182	CcSEcCtD
Phenoxybenzamine—Somnolence—Doxorubicin—hematologic cancer	8.71e-05	0.00174	CcSEcCtD
Phenoxybenzamine—Fatigue—Doxorubicin—hematologic cancer	8.45e-05	0.00168	CcSEcCtD
Phenoxybenzamine—Toremifene—ABCB1—hematologic cancer	8.2e-05	0.0619	CrCbGaD
Phenoxybenzamine—Asthenia—Methotrexate—hematologic cancer	8.12e-05	0.00162	CcSEcCtD
Phenoxybenzamine—Fenoprofen—ALB—hematologic cancer	8.09e-05	0.0612	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCG2—hematologic cancer	7.87e-05	0.0594	CrCbGaD
Phenoxybenzamine—Tamoxifen—ESR1—hematologic cancer	7.71e-05	0.0582	CrCbGaD
Phenoxybenzamine—Asthenia—Epirubicin—hematologic cancer	7.6e-05	0.00151	CcSEcCtD
Phenoxybenzamine—Clomifene—ABCB1—hematologic cancer	7.08e-05	0.0535	CrCbGaD
Phenoxybenzamine—Asthenia—Doxorubicin—hematologic cancer	7.03e-05	0.0014	CcSEcCtD
Phenoxybenzamine—Propafenone—ABCB1—hematologic cancer	5.77e-05	0.0436	CrCbGaD
Phenoxybenzamine—Bepridil—ABCB1—hematologic cancer	5.15e-05	0.0389	CrCbGaD
Phenoxybenzamine—Fentanyl—ABCB1—hematologic cancer	4.73e-05	0.0358	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCB1—hematologic cancer	3.27e-05	0.0247	CrCbGaD
Phenoxybenzamine—Methadone—ABCB1—hematologic cancer	3.25e-05	0.0245	CrCbGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3R1—hematologic cancer	1.33e-06	8.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.32e-06	8.49e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—STAT3—hematologic cancer	1.32e-06	8.46e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—NRAS—hematologic cancer	1.32e-06	8.44e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	1.31e-06	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.31e-06	8.41e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	1.31e-06	8.4e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTEN—hematologic cancer	1.31e-06	8.39e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PIK3CA—hematologic cancer	1.31e-06	8.37e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.3e-06	8.35e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MDM2—hematologic cancer	1.3e-06	8.34e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KRAS—hematologic cancer	1.3e-06	8.33e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.3e-06	8.33e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MYC—hematologic cancer	1.3e-06	8.32e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MYC—hematologic cancer	1.3e-06	8.31e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.29e-06	8.31e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—TGFB1—hematologic cancer	1.29e-06	8.3e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	1.29e-06	8.29e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.29e-06	8.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MAPK3—hematologic cancer	1.29e-06	8.28e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MAPK3—hematologic cancer	1.29e-06	8.28e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.29e-06	8.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JAK2—hematologic cancer	1.29e-06	8.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JAK2—hematologic cancer	1.29e-06	8.27e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.29e-06	8.26e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	1.28e-06	8.21e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.28e-06	8.2e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.28e-06	8.18e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.27e-06	8.17e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.27e-06	8.13e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CB—hematologic cancer	1.26e-06	8.11e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MTOR—hematologic cancer	1.26e-06	8.11e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—hematologic cancer	1.26e-06	8.11e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—hematologic cancer	1.26e-06	8.11e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PIK3CA—hematologic cancer	1.26e-06	8.1e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.26e-06	8.1e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.26e-06	8.09e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	1.26e-06	8.08e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.26e-06	8.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MDM2—hematologic cancer	1.26e-06	8.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MDM2—hematologic cancer	1.26e-06	8.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—hematologic cancer	1.26e-06	8.06e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—hematologic cancer	1.26e-06	8.06e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—hematologic cancer	1.25e-06	8.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—hematologic cancer	1.25e-06	8.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—hematologic cancer	1.25e-06	8.03e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—hematologic cancer	1.25e-06	8.03e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—EP300—hematologic cancer	1.25e-06	8e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	1.24e-06	7.98e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.24e-06	7.96e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.24e-06	7.96e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.24e-06	7.96e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.24e-06	7.96e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.24e-06	7.95e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	1.23e-06	7.91e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.23e-06	7.89e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	1.23e-06	7.86e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CB—hematologic cancer	1.22e-06	7.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MTOR—hematologic cancer	1.22e-06	7.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MTOR—hematologic cancer	1.22e-06	7.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CB—hematologic cancer	1.22e-06	7.85e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	1.22e-06	7.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	1.21e-06	7.78e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—hematologic cancer	1.21e-06	7.75e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—EP300—hematologic cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—EP300—hematologic cancer	1.21e-06	7.74e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.2e-06	7.72e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.2e-06	7.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—hematologic cancer	1.2e-06	7.69e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.2e-06	7.69e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	1.2e-06	7.68e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.2e-06	7.67e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	1.19e-06	7.66e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PIK3CA—hematologic cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.19e-06	7.65e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1B—hematologic cancer	1.19e-06	7.62e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.17e-06	7.52e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.17e-06	7.5e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—hematologic cancer	1.17e-06	7.49e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—hematologic cancer	1.17e-06	7.49e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.16e-06	7.47e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CASP3—hematologic cancer	1.16e-06	7.46e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—hematologic cancer	1.16e-06	7.45e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—hematologic cancer	1.16e-06	7.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—hematologic cancer	1.16e-06	7.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—hematologic cancer	1.16e-06	7.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PIK3CA—hematologic cancer	1.15e-06	7.4e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PIK3CA—hematologic cancer	1.15e-06	7.4e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.15e-06	7.4e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.15e-06	7.38e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1B—hematologic cancer	1.15e-06	7.37e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1B—hematologic cancer	1.15e-06	7.37e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.14e-06	7.33e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	1.14e-06	7.32e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	1.13e-06	7.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—hematologic cancer	1.13e-06	7.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—JUN—hematologic cancer	1.13e-06	7.25e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CASP3—hematologic cancer	1.13e-06	7.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CASP3—hematologic cancer	1.13e-06	7.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—hematologic cancer	1.12e-06	7.21e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—hematologic cancer	1.12e-06	7.21e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—hematologic cancer	1.12e-06	7.17e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—hematologic cancer	1.12e-06	7.17e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.11e-06	7.15e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	1.11e-06	7.15e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.11e-06	7.13e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—hematologic cancer	1.1e-06	7.08e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.1e-06	7.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PIK3CA—hematologic cancer	1.1e-06	7.06e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-06	7.05e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.1e-06	7.04e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1A—hematologic cancer	1.1e-06	7.03e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—hematologic cancer	1.1e-06	7.03e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—hematologic cancer	1.1e-06	7.03e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JUN—hematologic cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JUN—hematologic cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—hematologic cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	1.09e-06	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.08e-06	6.94e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	1.08e-06	6.91e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.07e-06	6.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK8—hematologic cancer	1.07e-06	6.86e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.07e-06	6.86e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.07e-06	6.86e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—hematologic cancer	1.07e-06	6.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—hematologic cancer	1.07e-06	6.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—hematologic cancer	1.07e-06	6.84e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PIK3CA—hematologic cancer	1.07e-06	6.83e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PIK3CA—hematologic cancer	1.07e-06	6.83e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—hematologic cancer	1.06e-06	6.82e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1A—hematologic cancer	1.06e-06	6.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1A—hematologic cancer	1.06e-06	6.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—hematologic cancer	1.06e-06	6.78e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—hematologic cancer	1.06e-06	6.78e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—hematologic cancer	1.06e-06	6.78e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—hematologic cancer	1.05e-06	6.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EP300—hematologic cancer	1.04e-06	6.69e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	1.04e-06	6.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK8—hematologic cancer	1.03e-06	6.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK8—hematologic cancer	1.03e-06	6.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—hematologic cancer	1.03e-06	6.62e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—hematologic cancer	1.03e-06	6.62e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	1.03e-06	6.61e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.02e-06	6.57e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.02e-06	6.57e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—hematologic cancer	1.02e-06	6.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—hematologic cancer	1.02e-06	6.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—hematologic cancer	1.02e-06	6.54e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	1.02e-06	6.53e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—hematologic cancer	1.02e-06	6.52e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SRC—hematologic cancer	1.01e-06	6.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.01e-06	6.48e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EP300—hematologic cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EP300—hematologic cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	1.01e-06	6.47e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	1.01e-06	6.46e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	9.96e-07	6.39e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	9.93e-07	6.37e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	9.91e-07	6.36e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	9.9e-07	6.35e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—hematologic cancer	9.87e-07	6.33e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	9.86e-07	6.33e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—hematologic cancer	9.85e-07	6.32e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—hematologic cancer	9.85e-07	6.32e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SRC—hematologic cancer	9.81e-07	6.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SRC—hematologic cancer	9.81e-07	6.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—hematologic cancer	9.78e-07	6.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—NRAS—hematologic cancer	9.75e-07	6.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—hematologic cancer	9.75e-07	6.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—hematologic cancer	9.74e-07	6.25e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—hematologic cancer	9.74e-07	6.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—hematologic cancer	9.74e-07	6.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	9.63e-07	6.18e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—hematologic cancer	9.55e-07	6.13e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—hematologic cancer	9.55e-07	6.13e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	9.47e-07	6.08e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—hematologic cancer	9.46e-07	6.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—hematologic cancer	9.46e-07	6.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—NRAS—hematologic cancer	9.43e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—NRAS—hematologic cancer	9.43e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—hematologic cancer	9.43e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—hematologic cancer	9.43e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—hematologic cancer	9.42e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—hematologic cancer	9.42e-07	6.05e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK3—hematologic cancer	9.34e-07	5.99e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PIK3CA—hematologic cancer	9.22e-07	5.92e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.22e-07	5.91e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	9.21e-07	5.91e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	9.2e-07	5.9e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	9.1e-07	5.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	9.1e-07	5.84e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—hematologic cancer	9.08e-07	5.83e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	9.07e-07	5.82e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—hematologic cancer	9.06e-07	5.81e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK3—hematologic cancer	9.03e-07	5.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK3—hematologic cancer	9.03e-07	5.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—hematologic cancer	9e-07	5.77e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	8.98e-07	5.76e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PIK3CA—hematologic cancer	8.92e-07	5.72e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PIK3CA—hematologic cancer	8.92e-07	5.72e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	8.8e-07	5.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—hematologic cancer	8.79e-07	5.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—hematologic cancer	8.79e-07	5.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—hematologic cancer	8.77e-07	5.62e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—hematologic cancer	8.77e-07	5.62e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—hematologic cancer	8.7e-07	5.58e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—hematologic cancer	8.7e-07	5.58e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.55e-07	5.48e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	8.5e-07	5.45e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	8.45e-07	5.42e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	8.41e-07	5.4e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—hematologic cancer	8.39e-07	5.38e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	8.36e-07	5.37e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—hematologic cancer	8.26e-07	5.3e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	8.18e-07	5.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—hematologic cancer	8.12e-07	5.21e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—hematologic cancer	8.12e-07	5.21e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.1e-07	5.2e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	8.05e-07	5.17e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—hematologic cancer	8e-07	5.13e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	7.82e-07	5.02e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CA—hematologic cancer	7.71e-07	4.95e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.65e-07	4.91e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—hematologic cancer	7.53e-07	4.83e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	7.48e-07	4.8e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—hematologic cancer	7.46e-07	4.79e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CA—hematologic cancer	7.46e-07	4.79e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CA—hematologic cancer	7.46e-07	4.79e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	7.43e-07	4.77e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—hematologic cancer	7.29e-07	4.68e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—hematologic cancer	7.29e-07	4.68e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—hematologic cancer	7.22e-07	4.63e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—hematologic cancer	7.22e-07	4.63e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—hematologic cancer	7.13e-07	4.58e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.06e-07	4.53e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	6.9e-07	4.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—hematologic cancer	6.9e-07	4.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—hematologic cancer	6.9e-07	4.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—hematologic cancer	6.83e-07	4.38e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—hematologic cancer	6.61e-07	4.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—hematologic cancer	6.61e-07	4.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—hematologic cancer	6.3e-07	4.04e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.1e-07	3.92e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—hematologic cancer	6.09e-07	3.91e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—hematologic cancer	6.09e-07	3.91e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—EP300—hematologic cancer	5.82e-07	3.73e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.31e-07	2.76e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.52e-07	2.26e-06	CbGpPWpGaD
